Age-standardisation when target setting and auditing performance of Down syndrome screening programmes

Prenatal Diagnosis

Volumn 24, Issue 11, 2004, Pages 851-856

  Cuckle, Howard ^a,g   Aitken, David ^b   Goodburn, Sandra ^c   Senior, Brian ^d   Spencer, Kevin ^e   Standing, Sue ^f  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Medical Genetics   (United Kingdom)

^c Clin Genet and Clin Biochemistry   (United Kingdom)

^d Bolton Royal Infirmary   (United Kingdom)

^e HAROLD WOOD HOSPITAL   (United Kingdom)

^f W Midlands Antenatal Serum S S   (United Kingdom)

^g Leeds Screening Centre   (United Kingdom)

Author keywords

Down syndrome; Maternal age; Maternal serum; Screening; Standardised rates

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DOWN SYNDROME; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MATERNAL AGE; MEDICAL AUDIT; NORMAL DISTRIBUTION; PERFORMANCE; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; SECOND TRIMESTER PREGNANCY; STANDARD; STANDARDIZATION; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; DOWN SYNDROME; ENGLAND; FEMALE; HUMANS; MATERNAL AGE; MEDICAL AUDIT; META-ANALYSIS; NORMAL DISTRIBUTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 9644262522     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.990     Document Type: Article

References (12)

1. Aitken DA, Crossley JA. 1997. The Glasgow ratio method. In Screening for Down syndrome in the First Trimester, Grudzinskas JG, Ward RHT (eds). RCOG Press: London; 67-79.
2. Crossley JA, Aitken DA, Berry E, Connor JM. 1994. Impact of a regional screening programme using maternal serum alpha-fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the West of Scotland. J Med Screen 1: 180-183.
3. Cuckle HS. 1994. Down's Syndrome Screening: the use of models in risk calculation, formulating policy, informing users and quality assessment. Proc UK NEQAS Meeting 1: 112-119.
4. Cuckle H. 1995. Improved parameters for risk estimation in Down's syndrome screening. Prenat Diagn 15: 1057-1065.
5. Cuckle H. 1999. Down syndrome fetal loss rate in early pregnancy. Prenat Diagn 19: 1177-1179.
6. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94: 387-402.
7. Goodburn SF, Yates JR, Raggatt PR, et al. 1994. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme. Prenat Diagn 14: 391-402.
8. Knight GJ, Palomaki GE. 1994. Epidemiologic monitoring and quality control of prenatal screening. Proc UK NEQAS Meeting 1: 120-126.
9. Office of National Statistics. 1993-2004. Birth Statistics Series FMI 20-31.
10. Royston P, Thompson SG. 1992. Model-based screening by risk with application to Down's syndrome. Stats Med 11: 257-268.
11. Spencer K. 1999. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol 106: 1287-1293.
12. van der Veen WJ, Beekhuis JR, Cornel MC, Mantingh A, de Walle HE, de Wolf BT. 1997. A demographic approach to the assessment of Down syndrome screening performance. Prenat Diagn 17(8): 717-724.